Clinical trial
Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity
NCT07605572 is registered in ClinicalTrials.gov with Attikon Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity
- Lead sponsor
- Attikon Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 1, 2026
- Completion date
- February 28, 2027
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cornea, diabete mellitus, diabetes type 2, dry eye disease (ded), glp-1, ocular surface